Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 2 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 37 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PHARMAELA from Quaregnon, company number BE0802941155, closed financial year 2025 with a result of € -30,599 after tax. For that financial year PHARMAELA recorded a gross margin of € 51,469 and equity of € -18,810. Compared with financial year 2024, the result moved from € 1,788 to € -30,599. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 5, 2026.
€ -18,810
▼ € 30,599 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -30,599
▼ still € 1,788 profit in 2024
Profit after tax over the fiscal year.
€ 8,836
▼ 34% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -28,810.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 51,078
▼ 33% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 278
▼ 58% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 91,554
▲ 267% vs 2024
€ 44,084 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 171,436
▼ 10% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 11,509
▼ 39% vs 2024
Taxes, VAT and social contributions still to pay.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 121,940 | € 51,469 | ▼ 58% |
| Profit after taxes | € 1,788 | € -30,599 | ▼ € 32,387 |
| Equity | € 11,788 | € -18,810 | ▼ € 30,599 |
| Total debts | € 278,419 | € 304,924 | ▲ 10% |
| Cash | € 13,472 | € 8,836 | ▼ 34% |
| Retained profit | € 1,788 | € -28,810 | ▼ € 30,599 |
| Bank debt | € 24,941 | € 91,554 | ▲ 267% |
| Balance sheet total | € 290,207 | € 286,114 | ▼ 1% |
Key figures of PHARMAELA, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMAELA?
What happened at PHARMAELA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 30,599 (▼ € 32,387 vs 2024). Source: NBB ↗
- New establishment in Quaregnon. KBO
- OUSSAMA ELAMINE became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 1,788 profit in 2024 to € 30,599 loss in 2025.
Paid € 1,000 in corporate taxes since 2024.
Best year ever: 2024, with € 1,788 profit.
Management
Behind PHARMAELA is OUSSAMA ELAMINE.
Directors
According to the 2025 annual accounts
OUSSAMA ELAMINE
Director
since 2023
Establishments
Establishment units
Physical locations of this company
Rue Paul Pastur 320
7390 Quaregnon
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0802.941.155
- VAT number
- BE 0802.941.155
- Registered office
- Rue Paul Pastur 320, 7390 Quaregnon
- Names & denominations
- PHARMAELA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 20 June 2023
- Peppol
- Active · Active since 3 Feb 2026
- Contact
- [email protected] +32487152652
- Activities · NACE
Detailhandel in farmaceutische producten
Detailhandel in cosmetica en toiletartikelen
Overige detailhandel in nieuwe artikelen neg